RIL
XENE icon

Rothschild Investment LLC’s Xenon Pharmaceuticals XENE Stock Holding History

Rothschild Investment LLC’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21K Buy
136
+10
+8% +$555 ﹤0.01% 2004
2026
Q1 		$7.33K Buy
126
+15
+14% +$691 ﹤0.01% 1854
2025
Q4 		$4.97K Sell
111
-4
-3% -$168 ﹤0.01% 1880
2025
Q3 		$4.62K Sell
115
-15
-12% -$528 ﹤0.01% 1743
2025
Q2 		$4.07K Buy
+130
New +$4.24K ﹤0.01% 1609

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Rothschild Investment LLC's XENE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Xenon Pharmaceuticals (XENE) stake by 7.9% in Q2 2026, buying an estimated $555 and bringing the position to 136 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Rothschild Investment LLC first reported a position in XENE in Q2 2025 and has held it in 5 quarters since. 96 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Rothschild Investment LLC held 136 shares of Xenon Pharmaceuticals worth $8.21K as of Q2 2026.
  • Rothschild Investment LLC bought 10 Xenon Pharmaceuticals shares in Q2 2026, an estimated $555.
  • Xenon Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2004 holding.
  • Rothschild Investment LLC first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 96 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.